Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cold Induced Changes in Human Subcutaneous White Adipose
NCT02596776Phase 1Completed
- Start
- Mar 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of propranolol in obesity and metabolic syndrome (3 arms). Primary endpoints: White Adipose Tissue changes during repeated exposure to cold temperatures at 28 weeks, White Adipose Tissue changes following Propranolol dosing at 17 days and 1 more. Started Mar 2016; status: completed.
02
Drugs
propranolol
03
Conditions
obesitymetabolic syndrome
Beyond the preview
Go deeper on NCT02596776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596776.